These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31091273)

  • 1. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.
    Shin S; Kim TH; Jeong SW; Chung SE; Lee DY; Kim DH; Shin BS
    PLoS One; 2019; 14(5):e0216875. PubMed ID: 31091273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case Study.
    Shin S; Kim TH; Lee DY; Chung SE; Lee JB; Kim DH; Shin BS
    AAPS J; 2020 Jan; 22(2):27. PubMed ID: 31938935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo gastric residence and gastroprotective effect of floating gastroretentive tablet of DA-9601, an extract of Artemisia asiatica, in beagle dogs.
    Kim JS; Cha KH; Kang SY; Won D; Jang SW; Son M; Son MH; Choi HJ; Lee YW; Kang MJ
    Drug Des Devel Ther; 2016; 10():1917-25. PubMed ID: 27354765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.
    Sankar R; Jain SK
    Drug Des Devel Ther; 2013; 7():1455-69. PubMed ID: 24348022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
    El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
    Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
    Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
    Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-Printed Gastroretentive Sustained Release Drug Delivery System by Applying Design of Experiment Approach.
    Jeong HM; Weon KY; Shin BS; Shin S
    Molecules; 2020 May; 25(10):. PubMed ID: 32429452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs.
    Yang Q; Hu Q
    Eur J Drug Metab Pharmacokinet; 2006; 31(1):17-20. PubMed ID: 16715778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
    Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
    Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of gastro-swelling/gastro-floating sustained-release tablets of brivaracetam for epilepsy therapy.
    Hou Z; Cheng X; Zhao X; Lin J; Zhang H; Li Y; Ding J
    Int J Pharm; 2023 Sep; 644():123301. PubMed ID: 37572859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
    Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
    Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.
    Guguloth M; Bomma R; Veerabrahma K
    PDA J Pharm Sci Technol; 2011; 65(3):198-206. PubMed ID: 22293231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastro-floating tablets of cephalexin: preparation and in vitro/in vivo evaluation.
    Yin L; Qin C; Chen K; Zhu C; Cao H; Zhou J; He W; Zhang Q
    Int J Pharm; 2013 Aug; 452(1-2):241-8. PubMed ID: 23680730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies.
    El Gamal SS; Naggar VF; Allam AN
    Drug Dev Ind Pharm; 2011 Jul; 37(7):855-67. PubMed ID: 21401342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swellable and porous bilayer tablet for gastroretentive drug delivery: Preparation and in vitro-in vivo evaluation.
    Hwang KM; Nguyen TT; Seok SH; Jo HI; Cho CH; Hwang KM; Kim JY; Park CW; Rhee YS; Park ES
    Int J Pharm; 2019 Dec; 572():118783. PubMed ID: 31678393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
    Liu H; Pan W; Ke P; Dong Y; Ji L
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexibility of 3D Extruded Printing for a Novel Controlled-Release Puerarin Gastric Floating Tablet: Design of Internal Structure.
    Li P; Zhang S; Sun W; Cui M; Wen H; Li Q; Pan W; Yang X
    AAPS PharmSciTech; 2019 Jun; 20(6):236. PubMed ID: 31236762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems.
    Fu J; Yin H; Yu X; Xie C; Jiang H; Jin Y; Sheng F
    Int J Pharm; 2018 Oct; 549(1-2):370-379. PubMed ID: 30107218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.